Order Article Reprints

Kotopoulis S, Popa M, Mayoral Safont M, Murvold E, Haugse R, Langer A, Dimcevski G, Lam C, Bjånes T, Gilja OH, et al. SonoVue^® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma? Pharmaceutics. 2022; 14(1):98. https://doi.org/10.3390/pharmaceutics14010098

Kotopoulis, Spiros, Mihaela Popa, Mireia Mayoral Safont, Elisa Murvold, Ragnhild Haugse, Anika Langer, Georg Dimcevski, Christina Lam, Tormod Bjånes, Odd Helge Gilja, and et al. 2022. "SonoVue^® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?" Pharmaceutics 14, no. 1: 98. https://doi.org/10.3390/pharmaceutics14010098

Kotopoulis, S., Popa, M., Mayoral Safont, M., Murvold, E., Haugse, R., Langer, A., Dimcevski, G., Lam, C., Bjånes, T., Gilja, O. H., & Cormack, E. M. (2022). SonoVue^® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma? Pharmaceutics, 14(1), 98. https://doi.org/10.3390/pharmaceutics14010098